CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ADMA — Adma Biologics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ADMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,515,011
-$1,367,894 QoQ
Shares Held
2,092,594
-0.2% QoQ
Ownership
0.934%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 323 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. ADMA ranks #79 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in ADMA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,515,011 | 2,092,594 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,882,905 | 2,095,772 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $41,180,593 | 2,257,708 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $34,608,814 | 2,360,765 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $45,561,893 | 2,502,026 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $48,846,179 | 2,462,005 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $41,851,042 | 2,440,294 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $48,006,644 | 2,401,533 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $24,060,712 | 2,152,121 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $11,715,792 | 1,775,120 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $7,397,897 | 1,636,703 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $5,761,458 | 1,609,346 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,101,281 | 569,453 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,860,954 | 562,222 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,885,718 | 486,010 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,162,055 | 478,212 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $945,594 | 477,573 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $126,685 | 69,227 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $97,610 | 69,227 | Shares | Sole | 2022-02-11 | |
| 2021-06-30 | $94,283 | 58,927 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $311,967 | 177,254 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $306,163 | 157,007 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $346,382 | 144,930 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $450,127 | 153,627 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $498,971 | 173,254 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||